These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Prediction of response to anticancer immunotherapy using gene signatures. Wang E; Bedognetti D; Marincola FM J Clin Oncol; 2013 Jul; 31(19):2369-71. PubMed ID: 23715576 [No Abstract] [Full Text] [Related]
13. Development of autoantibody signatures as novel diagnostic biomarkers of non-small cell lung cancer. Wu L; Chang W; Zhao J; Yu Y; Tan X; Su T; Zhao L; Huang S; Liu S; Cao G Clin Cancer Res; 2010 Jul; 16(14):3760-8. PubMed ID: 20501620 [TBL] [Abstract][Full Text] [Related]
14. Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trials. De Pas T; Giovannini M; Rescigno M; Catania C; Toffalorio F; Spitaleri G; Delmonte A; Barberis M; Spaggiari L; Solli P; Veronesi G; De Braud F Crit Rev Oncol Hematol; 2012 Sep; 83(3):432-43. PubMed ID: 22366114 [TBL] [Abstract][Full Text] [Related]
15. Active immunotherapy for non-small-cell lung cancer: moving toward a reality. Perez CA; Santos ES; Raez LE Expert Rev Anticancer Ther; 2011 Oct; 11(10):1599-605. PubMed ID: 21999133 [TBL] [Abstract][Full Text] [Related]
16. Non-small-cell lung cancer vaccine therapy: a concise review. O'Mahony D; Kummar S; Gutierrez ME J Clin Oncol; 2005 Dec; 23(35):9022-8. PubMed ID: 16219932 [TBL] [Abstract][Full Text] [Related]
17. MAGRIT: the largest-ever phase III lung cancer trial aims to establish a novel tumor-specific approach to therapy. Tyagi P; Mirakhur B Clin Lung Cancer; 2009 Sep; 10(5):371-4. PubMed ID: 19808198 [TBL] [Abstract][Full Text] [Related]
18. [Monoclonal antibodies in the diagnosis and therapy of lung cancer]. Campobasso N; Dammacco F Recenti Prog Med; 1991 Dec; 82(12):642-51. PubMed ID: 1667710 [TBL] [Abstract][Full Text] [Related]